Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ heat shock protein family member B13 (DNAJB13) is a type II Hsp40 co-chaperone protein highly expressed in testis and essential for the structure and motility of cilia and sperm flagella[2][3]. It localizes to the radial spokes of the axoneme—an internal scaffold in flagella/cilia—and plays a key role in stabilizing and assembling these structures, which are fundamental for sperm movement and ciliary beating in respiratory epithelia[2][3][1]. DNAJB13 interacts with septin 4 in the sperm annulus and is required during terminal sperm differentiation. Loss-of-function variants are directly linked to primary ciliary dyskinesia—a disorder of dysfunctional cilia leading to respiratory disease—and to male infertility, primarily via abnormal sperm motility (asthenozoospermia) and morphology[2][3][1]. There is no evidence DNAJB13 is a direct target of pharmacological agents. Rather, its clinical relevance is as a genetic cause of ciliopathies and infertility, and as a biomarker in these contexts[2][3].
Not applicable. No drugs or small molecules with defined mechanism of action targeting DNAJB13[3][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family member B13 (DNAJB13).